DNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and Beyond
- PMID:27258260
- PMCID: PMC4926390
- DOI: 10.3390/ijms17060856
DNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and Beyond
Abstract
Schizophrenia and autism spectrum disorder (ASD) are multi-factorial and multi-symptomatic psychiatric disorders, each affecting 0.5%-1% of the population worldwide. Both are characterized by impairments in cognitive functions, emotions and behaviour, and they undermine basic human processes of perception and judgment. Despite decades of extensive research, the aetiologies of schizophrenia and ASD are still poorly understood and remain a significant challenge to clinicians and scientists alike. Adding to this unsatisfactory situation, patients with schizophrenia or ASD often develop a variety of peripheral and systemic disturbances, one prominent example of which is cancer, which shows a direct (but sometimes inverse) comorbidity in people affected with schizophrenia and ASD. Cancer is a disease characterized by uncontrolled proliferation of cells, the molecular origin of which derives from mutations of a cell's DNA sequence. To counteract such mutations and repair damaged DNA, cells are equipped with intricate DNA repair pathways. Oxidative stress, oxidative DNA damage, and deficient repair of oxidative DNA lesions repair have been proposed to contribute to the development of schizophrenia and ASD. In this article, we summarize the current evidence of cancer comorbidity in these brain disorders and discuss the putative roles of oxidative stress, DNA damage and DNA repair in the aetiopathology of schizophrenia and ASD.
Keywords: DNA base excision repair; XRCC1; autism; cancer; neurodevelopmental disorders; oxidative DNA damage; oxidative stress; schizophrenia.
Figures

Similar articles
- Deficient DNA base-excision repair in the forebrain leads to a sex-specific anxiety-like phenotype in mice.Mueller FS, Amport R, Notter T, Schalbetter SM, Lin HY, Garajova Z, Amini P, Weber-Stadlbauer U, Markkanen E.Mueller FS, et al.BMC Biol. 2022 Jul 30;20(1):170. doi: 10.1186/s12915-022-01377-1.BMC Biol. 2022.PMID:35907861Free PMC article.
- Active ribosomal genes, translational homeostasis and oxidative stress in the pathogenesis of schizophrenia and autism.Porokhovnik LN, Passekov VP, Gorbachevskaya NL, Sorokin AB, Veiko NN, Lyapunova NA.Porokhovnik LN, et al.Psychiatr Genet. 2015 Apr;25(2):79-87. doi: 10.1097/YPG.0000000000000076.Psychiatr Genet. 2015.PMID:25710845
- [Social cognition in schizophrenia and autism spectrum disorder: Points of convergence and functional differences].Le Gall E, Iakimova G.Le Gall E, et al.Encephale. 2018 Dec;44(6):523-537. doi: 10.1016/j.encep.2018.03.004. Epub 2018 Aug 16.Encephale. 2018.PMID:30122298Review.French.
- Neonatal and regressive forms of autism: Diseases with similar symptoms but a different etiology.Barbeau WE.Barbeau WE.Med Hypotheses. 2017 Nov;109:46-52. doi: 10.1016/j.mehy.2017.09.015. Epub 2017 Sep 20.Med Hypotheses. 2017.PMID:29150292
- [Epigenetics' implication in autism spectrum disorders: A review].Hamza M, Halayem S, Mrad R, Bourgou S, Charfi F, Belhadj A.Hamza M, et al.Encephale. 2017 Aug;43(4):374-381. doi: 10.1016/j.encep.2016.07.007. Epub 2016 Sep 28.Encephale. 2017.PMID:27692350Review.French.
Cited by
- Differential cell cycle checkpoint evasion by PTEN germline mutations associated with dichotomous phenotypes of cancer versus autism spectrum disorder.Hitomi M, Venegas J, Kang SC, Eng C.Hitomi M, et al.Oncogene. 2023 Dec;42(50):3698-3707. doi: 10.1038/s41388-023-02867-4. Epub 2023 Nov 1.Oncogene. 2023.PMID:37907589
- Association of NEF2L2 Rs35652124 Polymorphism with Nrf2 Induction and Genotoxic Stress Biomarkers in Autism.Porokhovnik LN, Pisarev VM, Chumachenko AG, Chudakova JM, Ershova ES, Veiko NN, Gorbachevskaya NL, Mamokhina UA, Sorokin AB, Basova AY, Lapshin MS, L Izhevskaya V, Kostyuk SV.Porokhovnik LN, et al.Genes (Basel). 2023 Mar 15;14(3):718. doi: 10.3390/genes14030718.Genes (Basel). 2023.PMID:36980990Free PMC article.
- Salubrious effects of proanthocyanidins on behavioral phenotypes and DNA repair deficiency in the BTBR mouse model of autism.Alhusain AF, Mahmoud MA, Alhamami HN, Ebrahim Alobid S, Ansari MA, Ahmad SF, Nadeem A, Bakheet SA, Harisa GI, Attia SM.Alhusain AF, et al.Saudi Pharm J. 2024 Nov;32(11):102187. doi: 10.1016/j.jsps.2024.102187. Epub 2024 Oct 13.Saudi Pharm J. 2024.PMID:39493830Free PMC article.
- Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?Wang H, Dharmalingam P, Vasquez V, Mitra J, Boldogh I, Rao KS, Kent TA, Mitra S, Hegde ML.Wang H, et al.Mech Ageing Dev. 2017 Jan;161(Pt A):163-176. doi: 10.1016/j.mad.2016.09.005. Epub 2016 Sep 20.Mech Ageing Dev. 2017.PMID:27663141Free PMC article.Review.
- Opioid induces increased DNA damage in prefrontal cortex and nucleus accumbens.Wang Y, Singh A, Li G, Yue S, Hertel K, Wang ZJ.Wang Y, et al.Pharmacol Biochem Behav. 2023 Mar;224:173535. doi: 10.1016/j.pbb.2023.173535. Epub 2023 Mar 11.Pharmacol Biochem Behav. 2023.PMID:36907467Free PMC article.
References
- Whiteford H.A., Degenhardt L., Rehm J., Baxter A.J., Ferrari A.J., Erskine H.E., Charlson F.J., Norman R.E., Flaxman A.D., Johns N., et al. Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1575–1586. doi: 10.1016/S0140-6736(13)61611-6. - DOI - PubMed
Publication types
MeSH terms
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical